Two police constables held for robbing woman lawyer of Rs 8 lakh

Bengaluru, May 23: Karnataka reported 216 covid-19 positive cases in last 24 hours, marking the highest single day spike in the state ever since the first case was detected on 8 March. 187 of these 216 patients have recently returned from Maharashtra.

A 32-year old male resident of Bengaluru died on Saturday making it the 42nd fatality in the state.

The spike on Saturday takes the total number of covid-19 positive closer to the 2,000 mark and the number of active cases to 1,307 in the state, according to the daily health bulletin of the health department.

Yadgir in northern Karnataka recorded 72 cases on Saturday while Raichur recorded 40 cases. Cases in the sugarcane growing region of Mandya continued to rise as 28 people tested positive on Saturday that takes the total number of active cases to 211 as against Bengaluru that has 124.

Gadag registered 15 cases while Bengaluru recorded 4 cases.

Most of those who tested positive on Saturday had returned from other states, especially Maharashtra, one of the worst affected regions in the country.

The spike in cases comes even as the B.S.Yediyurappa-led state government is deliberating further easing of lockdown restrictions post 31 May. The state government has already resumed public bus and train services as well to facilitate inter-district movement of people that has added to fears of spreading the virus from cities to villages where healthcare infrastructure is poor and inadequate.

Karnataka will also see domestic flight arrivals from Monday.

In a statement on Saturday, Bengaluru International Airport said that it introduced ‘Parking-to-Boarding contactless’ journey.

“We have introduced innovative contactless procedures to minimise exposure at the Airport. These enhancements demonstrate our continued commitment to keep our passengers safe in this environment," said Hari Marar, managing director and chief executive of the airport said in a statement on Saturday.

Bengaluru, Jun 11: Most COVID-19 deaths in Karnataka occur when infected elderly people, those with Severe Acute Respiratory Illness (SARI) or any other symptoms delay reaching designated hospitals, a top official said.

Munish Moudgil, chief of COVID-19 War Room in the state, said most of those infected with the virus are brought to COVID-19 designated hospitals at a very late stage and recovery then becomes extremely tough.

He said about 65 per cent of those killed suffered from SARI and are aged above 60.

The death rate due to SARI is 43 per cent for those in the 40-60 age group, he said, releasing data on coronavirus deaths, to reporters.

In the same age group, the mortality due to Influenza Like Illness (ILI) was 17.4 per cent, whereas it is 11.1 per cent among people aged above 60 .

He said 25 per cent of symptomatic patients aged above 60 die due to the virus, while it was 10.7 per cent in the 40-60 age group.

The fatalities among those aged 60 is high even if they are asymptomatic, Mr Moudgil, who is secretary in the Department of Personnel and Administrative Reforms, said.

He said the average number of days spent at these hospitals by those who recovered is about 15 days, compared to 3.5 days for those who died of the virus.

Listen to the latest songs, only on JioSaavn.com

"Hence persons who are elderly and who have comorbidities or who have SARI must reach designated Covid hospitals at the earliest," Mr Moudgil said.

As of date, Karnataka has reported 69 COVID-19 deaths As many as 6,041 people have tested positive for COVID-19, including 2,862 discharges and 3,108 active cases.

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.